异基因造血干细胞移植后用于治疗T细胞急性淋巴细胞白血病或T细胞淋巴瘤的选择性组蛋白脱乙酰酶抑制剂 - Suppr

Selective histone deacetylase inhibitor after allo-HCT for T-cell acute lymphoblastic leukemia or T-cell lymphoma.

作者信息

Chen Weihao, Shi Jimin, Luo Yi, Yu Jian, Lai Xiaoyu, Liu Lizhen, Fu Huarui, Huang He, Zhao Yanmin

机构信息

Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, 311121, China.

出版信息

Bone Marrow Transplant. 2024 Apr;59(4):561-563. doi: 10.1038/s41409-023-02191-1. Epub 2024 Jan 23.

DOI:10.1038/s41409-023-02191-1

PMID:38263392

Abstract

摘要

相似文献

Selective histone deacetylase inhibitor after allo-HCT for T-cell acute lymphoblastic leukemia or T-cell lymphoma.异基因造血干细胞移植后用于治疗T细胞急性淋巴细胞白血病或T细胞淋巴瘤的选择性组蛋白脱乙酰酶抑制剂

Bone Marrow Transplant. 2024 Apr;59(4):561-563. doi: 10.1038/s41409-023-02191-1. Epub 2024 Jan 23.

[Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for T lymphoblastic leukemia/lymphoma].[异基因造血干细胞移植治疗T淋巴母细胞白血病/淋巴瘤的疗效及预后因素]

Zhonghua Xue Ye Xue Za Zhi. 2023 May 14;44(5):388-394. doi: 10.3760/cma.j.issn.0253-2727.2023.05.006.

Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas.组蛋白去乙酰化酶抑制剂下调 CCR4 表达，降低 CCR4 阳性成熟 T 细胞淋巴瘤中 mogamulizumab 的疗效。

Haematologica. 2018 Jan;103(1):126-135. doi: 10.3324/haematol.2017.177279. Epub 2017 Oct 12.

Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia.使用组蛋白去乙酰化酶抑制剂帕比司他对Notch1驱动的转录进行表观遗传靶向是一种针对T细胞急性淋巴细胞白血病的潜在疗法。

Leukemia. 2018 Jan;32(1):237-241. doi: 10.1038/leu.2017.282. Epub 2017 Sep 15.

Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.成熟 T 细胞和 NK/T 细胞淋巴瘤造血细胞移植适应证和时机的临床实践推荐：代表美国血液和骨髓移植学会指南委员会的国际合作努力。

Biol Blood Marrow Transplant. 2017 Nov;23(11):1826-1838. doi: 10.1016/j.bbmt.2017.07.027. Epub 2017 Aug 7.

Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.外周 T 细胞淋巴瘤中的造血细胞移植和过继细胞治疗。

Curr Hematol Malig Rep. 2020 Aug;15(4):316-332. doi: 10.1007/s11899-020-00590-5.

p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia.p21（WAF1）调节B细胞前体急性淋巴细胞白血病中的药物诱导凋亡和细胞周期阻滞。

Cell Cycle. 2015;14(22):3602-12. doi: 10.1080/15384101.2015.1100774.

Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient.培门冬酶、维奈克拉和奈拉滨：一名复发/难治性T细胞急性淋巴细胞白血病患者成功过渡到异基因造血干细胞移植的桥梁。

Ann Hematol. 2023 Jun;102(6):1599-1600. doi: 10.1007/s00277-023-05231-4. Epub 2023 Apr 26.

Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study.T细胞淋巴母细胞白血病/淋巴瘤异基因造血干细胞移植的结局：一项单中心研究。

Leuk Res. 2021 Sep;108:106627. doi: 10.1016/j.leukres.2021.106627. Epub 2021 May 18.

Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia.Blinatumomab 治疗与儿童 B 细胞急性淋巴细胞白血病患者异基因造血细胞移植后的良好结局相关。

Transplant Cell Ther. 2024 Feb;30(2):217-227. doi: 10.1016/j.jtct.2023.10.024. Epub 2023 Nov 4.

本文引用的文献

Chidamide maintenance therapy in high-risk T-ALL/T-LBL after allo-HSCT: a prospective, single-center, single-arm study.异基因造血干细胞移植后高危T细胞急性淋巴细胞白血病/ T淋巴母细胞淋巴瘤的西达本胺维持治疗：一项前瞻性、单中心、单臂研究。

Bone Marrow Transplant. 2023 Oct;58(10):1163-1166. doi: 10.1038/s41409-023-02045-w. Epub 2023 Jul 20.

GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma.无移植物抗宿主病、无复发生存为优化成人T细胞白血病/淋巴瘤的异基因造血干细胞移植提供了新线索。

Bone Marrow Transplant. 2021 Jan;56(1):155-166. doi: 10.1038/s41409-020-00996-y. Epub 2020 Jul 14.

The rapidly changing landscape in mature T-cell lymphoma (MTCL) biology and management.成熟 T 细胞淋巴瘤（MTCL）生物学和治疗的快速变化。

CA Cancer J Clin. 2020 Jan;70(1):47-70. doi: 10.3322/caac.21589. Epub 2019 Dec 9.

Allogeneic hematopoietic stem cell transplantation for T-cell lymphomas.异基因造血干细胞移植治疗 T 细胞淋巴瘤。

Blood. 2018 Jul 19;132(3):245-253. doi: 10.1182/blood-2018-01-791335. Epub 2018 Apr 26.

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China.西达本胺治疗复发或难治性外周T细胞淋巴瘤：一项中国多中心真实世界研究

J Hematol Oncol. 2017 Mar 15;10(1):69. doi: 10.1186/s13045-017-0439-6.

Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.青少年及成人早期T细胞前体急性淋巴细胞白血病/淋巴瘤（ETP-ALL/LBL）：一种高危亚型

Blood. 2016 Apr 14;127(15):1863-9. doi: 10.1182/blood-2015-08-661702. Epub 2016 Jan 8.

Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.一项关于西达本胺治疗复发或难治性外周 T 细胞淋巴瘤的多中心、开放标签、关键 II 期研究的结果。

Ann Oncol. 2015 Aug;26(8):1766-71. doi: 10.1093/annonc/mdv237. Epub 2015 Jun 23.

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.霍奇金淋巴瘤和非霍奇金淋巴瘤初始评估、分期及反应评估的建议：卢加诺分类

J Clin Oncol. 2014 Sep 20;32(27):3059-68. doi: 10.1200/JCO.2013.54.8800.

CS055 (Chidamide/HBI-8000), a novel histone deacetylase inhibitor, induces G1 arrest, ROS-dependent apoptosis and differentiation in human leukaemia cells.CS055（西达本胺/HBI-8000），一种新型组蛋白去乙酰化酶抑制剂，可诱导人白血病细胞 G1 期阻滞、ROS 依赖性凋亡和分化。

Biochem J. 2012 May 1;443(3):735-46. doi: 10.1042/BJ20111685.

Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity.西达本胺（CS055/HBI-8000）：一种新型苯酰胺类组蛋白去乙酰化酶抑制剂，具有抗肿瘤活性，并能增强免疫细胞介导的肿瘤细胞细胞毒性。

Cancer Chemother Pharmacol. 2012 Apr;69(4):901-9. doi: 10.1007/s00280-011-1766-x. Epub 2011 Nov 12.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Selective histone deacetylase inhibitor after allo-HCT for T-cell acute lymphoblastic leukemia or T-cell lymphoma.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

本文引用的文献